Evidence map›Paper›PMID 28555339›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2017

Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar

Satish K Garg, Viral N Shah, Halis K Akturk, Christie Beatson, Janet K Snell-Bergeon

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01825382 (Role of Mobile Technology to Improve Diabetes Care in Adults With Type 1 Diabetes), which is not on this map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01825382 phase4completednot on this map

Role of Mobile Technology to Improve Diabetes Care in Adults With Type 1 Diabetes: the REMOTE-T1D Study, a Pilot Study

TypeinterventionalSponsorUniversity of Colorado, DenverRan2012 to 2013Enrolled100ConditionsType 1 DiabetesArmsiBGStar meter
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Digital Health Technology in Diabetes Management in the Asia-Pacific Region: A Narrative Review of the Current Scenario and Future Outlook.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Smartphone-Based Technology in Diabetes Management.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Managing diabetes in the digital age.Clinical diabetes and endocrinology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Satish K GargBarbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA. Satish.garg@ucdenver.edu.
Viral N ShahBarbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA.
Halis K AkturkBarbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA.
Christie BeatsonBarbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA.
Janet K Snell-BergeonBarbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA.
University of Colorado Anschutz Medical Campus · US

Funding

Complications and Comorbidities of Type 1 DiabetesR01HL113029 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SNELL-BERGEON, JANET KATHLEEN · 2013 to 2016
$2.9M
NHLBI NIH HHS R01 HL113029
6 · The paper itself

Abstract

introductionThe role of mobile technology in patient-reported outcomes (PRO) and glycemic control in adults with type 1 diabetes (T1D) needs further evaluation.

methodsThe single-center, prospective, 6-month, open-label, investigator-initiated study randomized 100 subjects with T1D in a 1:1 fashion to a control group using self-monitoring of blood glucose (SMBG) with Accu-Chek Nano

resultsBaseline demographics and glycosylated hemoglobin (A1c) values were similar in the two groups. There was a significant decrease in A1c value at 6 months in iBGStar

conclusionThe use of iBGStar CLINICAL

trial registrationClinicalTrials.gov: NCT01825382.

fundingSanofi.

Indexed as

Continuous glucose monitoringDiabetesGlucometerHypoglycemiaiBGStariPhoneMobile technologySelf-monitoring of blood glucoseType 1 diabetes

Identifiers

PMID28555339
PMCPMC5544609
OpenAlexW2618316265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.